News

News-Medical.Net on MSN15h
Semaglutide clears liver inflammation and cuts fibrosis in MASH patients, trial shows
A phase 3 trial shows that once-weekly semaglutide significantly improves liver histology in patients with metabolic ...
inews.co.uk on MSN2h
Interest in weight-loss jabs is surging – here’s what semaglutide does to your body
Last year, more than 16 million people googled 'semaglutide' - sold under the brand names Wegovy and Ozempic - as demand for ...
The Express Tribune7h
Ozempic shows promise in reversing liver disease, research finds
Results showed that 62.9% of patients on Ozempic saw a reduction in liver inflammation, compared to 34.3% on placebo.
NewsNation on MSN4h
Ozempic, Wegovy could reverse severe liver disease, study suggests
Drugs made to treat diabetes and weight loss could stop or even reverse a severe liver disease, according to a new study. The ...
Pharmabiz8h
US FDA accepts Novo Nordisk’s NDA submission for oral semaglutide 25 mg for treatment of obesity
Plainsboro, New Jersey Monday, May 5, 2025, 14:00 Hrs [IST] ...
Best Life on MSN42m
Doctors Warn About Startling New Ozempic Side Effect That Causes a "Prematurely Aged Appearance"
There's a new side effect to Ozempic that is causing users to develop "Ozempic Mouth." Learn why semaglutide medications cause this and what you can to do counteract it. Don't let your weight loss ...
Hydreight Technologies Appoints Dr. Roebuck As a Director of the Company
Hydreight Technologies Inc. (TSXV: NURS) (OTCQB: HYDTF) (FSE: SO6) ("Hydreight" or the "Company"), a North American, fully integrated, mobile clinical network ...